Literature DB >> 3488938

Endoscopic sclerotherapy: lessons from a necropsy study.

D Papadimos, P Kerlin, O D Harris.   

Abstract

A retrospective necropsy survey of 13 patients who had received endoscopic injection sclerotherapy was carried out to study tissue changes induced and to determine the causes of death. These results were compared with autopsy findings in nine patients with portal hypertension, comparable for age, sex, and nature and severity of underlying liver disease, who had not received sclerotherapy. Although all treated patients had variceal thrombosis with an associated vasculitis, residual varices were usually present, probably reflecting the brief duration of treatment (median, 12 days). The major complications of sclerotherapy resulted from necrosis, with resultant mucosal ulceration and abscess formation. These features were not present in the control group. Complications contributing to death were hemorrhage in three patients, and in one sepsis with deep necrosis and periesophageal abscess formation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3488938     DOI: 10.1016/s0016-5107(86)71844-0

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  6 in total

Review 1.  Complications and hazards of gastrointestinal endoscopy.

Authors:  A Habr-Gama; J D Waye
Journal:  World J Surg       Date:  1989 Mar-Apr       Impact factor: 3.352

2.  Sonographic evaluation of the portal venous system after elective endoscopic sclerotherapy of esophageal varices.

Authors:  G C Caletti; E Brocchi; L Zani; L Bolondi; M Baraldini; V Rollo; L Barbara
Journal:  Surg Endosc       Date:  1987       Impact factor: 4.584

3.  Sclerotherapy of esophageal varices by consecutive injection of anhydrous ethanol: 1% polydocanol and thrombin.

Authors:  Y Kumagai; H Makuuchi; E Yamazaki
Journal:  Surg Endosc       Date:  1987       Impact factor: 4.584

4.  Prophylactic versus emergency sclerotherapy of large esophageal varices prior to liver transplantation.

Authors:  D H Van Thiel; V J Dindzans; R R Schade; M Rabinovitz; J S Gavaler
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

Review 5.  Proton pump inhibitors in cirrhosis: tradition or evidence based practice?

Authors:  Francesca Lodato; Francesco Azzaroli; Maria Di Girolamo; Valentina Feletti; Paolo Cecinato; Andrea Lisotti; Davide Festi; Enrico Roda; Giuseppe Mazzella
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

6.  Treatment of achalasia by injection of sclerosant substances: a long-term report.

Authors:  Manuel Moretó; Enrique Ojembarrena; Angel Barturen; Ignacio Casado
Journal:  Dig Dis Sci       Date:  2012-11-22       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.